Pricing Log in Create free account

Medpace Holdings, Inc. (MEDP) vs Revvity Inc. (RVTY)

Medpace Holdings, Inc. and Revvity Inc. are both Diagnostics & Research companies. Medpace Holdings, Inc. and Revvity Inc. are of similar size ($17.6B and $17.3B). Medpace Holdings, Inc. trades at the lower P/E: 35.6× against 72.7×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 24.7% against 4.05%. Medpace Holdings, Inc. has the higher net margin (17.7% vs 8.16%) and the lower return on invested capital (0.00% vs 2.38%). Across the 22 metrics below, Medpace Holdings, Inc. leads on 17 and Revvity Inc. on 5.

Valuation

Metric MEDP RVTY Diagnostics & Research median
P/E 35.56 72.69 35.56
P/S 6.26 5.85 4.37
P/B 40.16 2.36 3.06
Price to free cash flow 24.66 30.14 35.76
EV/EBITDA 27.87 24.77 24.35
EV/Sales 6.12 6.60 5.51
Earnings yield 2.81% 1.38% (1.89%)
Free cash flow yield 4.06% 3.32% (0.15%)

Profitability

Metric MEDP RVTY Diagnostics & Research median
Gross margin 72.35% 54.98% 50.89%
Operating margin 20.97% 12.32% (8.57%)
Net margin 17.67% 8.16% (6.37%)
Free cash flow margin 25.40% 19.58% 0.00%
Return on equity 162.15% 3.21% (2.92%)
Return on assets 27.09% 1.95% (6.71%)
Return on invested capital 0.00% 2.38% 0.00%

Growth

Metric MEDP RVTY Diagnostics & Research median
Revenue growth (TTM) 24.67% 4.05% 7.69%
EPS growth (last fiscal year) 20.98% (5.91%) 25.92%
Revenue growth, 5-year CAGR 22.27% 1.41% 7.40%
Net income growth, 5-year CAGR 25.50% (19.82%) 0.00%

Health

Metric MEDP RVTY Diagnostics & Research median
Debt to equity 0.00 0.44 0.11
Current ratio 0.73 1.80 2.02
Net debt to EBITDA (0.88) 3.00 0.70

Dividend

Metric MEDP RVTY Diagnostics & Research median
Dividend yield — 0.23% 0.66%
Payout ratio — 0.17 0.20

Size

Metric MEDP RVTY Diagnostics & Research median
Market cap 17.55b 17.26b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack